JS Link

127120 · KOSDAQ · Industrials · SMALL CAP

Updated contract terms.

JS Link updated a previously disclosed supply contract with Korea Research Institute of Bioscience and Biotechnology, now worth US$6.93M, about 47.64% of its recent annual revenue, running through Dec 2026.

Supply contract([Amended] Supply contract signed)· FILED 2026-03-27· RCEPT 20260327902081

US$6.93MContract value
47.64%vs. recent revenue
Dec 2026Throughfrom Dec 2024

Converted at 1 USD ≈ ₩1,508.36 (filing-date rate, 2026-03-27 close)

What happened

JS Link updated a previously disclosed supply contract with Korea Research Institute of Bioscience and Biotechnology, now worth US$6.93M, about 47.64% of its recent annual revenue, running through Dec 2026.

For context, this single contract equals about 47.64% of the company's most recent annual revenue.

CounterpartyKorea Research Institute of Bioscience and Biotechnology
Contract valueUS$6.93M
vs. recent revenue47.64%
ThroughDec 2026 (from Dec 2024)
Filed2026-03-27, [Amended] Supply contract signed
SourceDART rcept 20260327902081 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-27 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.